Cite
HARVARD Citation
Joerger, M. et al. (n.d.). 3066 Pharmacokinetically (PK)-guided dosing of paclitaxel in combination with carboplatin in advanced non-small cell lung cancer (NSCLC) is gender dependent: Updated results of the randomized CEPAC-TDM study. European journal of cancer. pp. S618-. [Online].